Jump to content

Covaxin: Bharat Biotech's Covid vaccine may get approval 'within next 24 hrs', says WHO official


Kool_SRG

Recommended Posts

4 hours ago, bhaigan said:

Covaxin ki inka approval raleda damn 

antha worst ga develop chesara covaxin ni

 

 

bro lets support it. Wholly indigenous not like astra zeneca licensed covishield. Lets not forget how that playboy Adar Poonwallah mocked Dr Krishna Ella (who quit a career in usa to make not so profitable vaccines in developing country) as maker of "pure water".

I am sure the procedures are lacking but they are solid company and they will get it.

  • Upvote 1
Link to comment
Share on other sites

6 hours ago, Telugodura456 said:

bro lets support it. Wholly indigenous not like astra zeneca licensed covishield. Lets not forget how that playboy Adar Poonwallah mocked Dr Krishna Ella (who quit a career in usa to make not so profitable vaccines in developing country) as maker of "pure water".

I am sure the procedures are lacking but they are solid company and they will get it.

10000+++

Link to comment
Share on other sites

7 hours ago, Telugodura456 said:

bro lets support it. Wholly indigenous not like astra zeneca licensed covishield. Lets not forget how that playboy Adar Poonwallah mocked Dr Krishna Ella (who quit a career in usa to make not so profitable vaccines in developing country) as maker of "pure water".

I am sure the procedures are lacking but they are solid company and they will get it.

it is the best vaccine one can get, chewthiyas don't understand reality

Link to comment
Share on other sites

2 hours ago, Kool_SRG said:

Ekkada ante eh oorlo ani kaadhu eh center PVT hospital or govt center?? 

Second dose kuda same center lo taken ani vachinda.. 

Govt center vaccine veyyinchina vadi name kuda vachindi..idem scam denamma CueOkF-shared.gif

Link to comment
Share on other sites

Covaxin emergency use: WHO seeks ‘additional clarifications’ from Bharat Biotech

The World Health Organisation (WHO) has said that additional clarifications from manufacturer are needed to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of Bharat Biotech's Covaxin. The technical advisory group will now meet on November 3 for a final assessment.

“The @WHO independent Technical Advisory Group (TAG) met today & asked for additional clarifications from the manufacturer @BharatBiotech to conduct a final EUL risk-benefit assessment for global use of #Covaxin. It will reconvene for the final assessment on Wednesday, 3 November if data is received soon," WHO chief scientist Dr Soumya Swaminathan said in a tweet.

The Technical Advisory Group for Emergency Use Listing (TAG-EUL) is an independent advisory group that provides recommendations to WHO on whether a Covid 19 vaccine can be listed for emergency use under the EUL procedure.

Bharat Biotech has been submitting data to WHO on a rolling basis and submitted additional information at the UN health body's request on September 27.

Covaxin, India's first indigenous COVID-19 vaccine, is developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research.

The Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant. In June, the company said it concluded the final analysis of Covaxin efficacy from Phase 3 trials.

Bharat Biotech's Covaxin and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India.

The WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Janssen, Moderna, and Sinopharm for emergency use.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...